Stock Events

Becton Dickinson 

€214.2
491
-€0.7-0.33% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
1.62%
Dividend
3.47

Upcoming

Dividends

1.62%Dividend Yield
10Y Growth
7.5%
5Y Growth
4.62%
3Y Growth
6.93%
1Y Growth
1.54%

Earnings

7NovConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
2.4
2.86
3.33
3.79
Expected EPS
3.794103
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BOX.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap105.2B
Medtronic competes directly with Becton Dickinson in the medical devices sector, particularly in areas like surgical instruments and diabetes care products.
Abbott Laboratories
ABT
Mkt Cap189.14B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products that compete with Becton Dickinson's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap227.74B
Thermo Fisher Scientific competes in the supply of laboratory equipment and consumables, directly challenging Becton Dickinson's life sciences segment.
Danaher
DHR
Mkt Cap193.63B
Danaher Corporation's life sciences and diagnostics divisions offer products that compete with Becton Dickinson's portfolio, especially in diagnostics and research.
Stryker
SYK
Mkt Cap124.93B
Stryker Corporation is a competitor in the medical technology field, particularly in surgical equipment and hospital beds, areas where Becton Dickinson also operates.
Boston Scientific
BSX
Mkt Cap112.2B
Boston Scientific Corporation competes with Becton Dickinson in the medical devices market, especially in areas like cardiovascular and endoscopy products.
Johnson & Johnson
JNJ
Mkt Cap386.65B
Johnson & Johnson's medical devices division offers products that compete across several of Becton Dickinson's key areas, including surgical instruments and infection prevention.
Hologic
HOLX
Mkt Cap19.43B
Hologic, Inc. competes with Becton Dickinson in the diagnostics and women's health sectors, offering similar products for cancer detection and surgical procedures.
Zimmer Biomet
ZBH
Mkt Cap22.01B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which overlaps with Becton Dickinson's solutions for surgical and rehabilitation products.
Intuitive Surgical
ISRG
Mkt Cap164.68B
Intuitive Surgical, Inc. competes with Becton Dickinson in the surgical instruments market, particularly with its robotic-assisted surgical systems.

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
CEO
Employees
75000
Country
DE
ISIN
US0758871091
WKN
000857675

Listings